This clinical trial develops and tests a cervical health program called Health is Wealth in promoting cervical cancer screening among African American and Sub Saharan African immigrants. The Health is Wealth program may promote screening and reduce perceived barriers to cervical cancer screening. This trial may also help researchers learn about the general awareness related to cancer screening, cultural factors related to willingness to complete cancer screening and preventative activities, and barriers and facilitators to cervical cancer screening and human papillomavirus self-sampling.
Additional locations may be listed on ClinicalTrials.gov for NCT04927494.
Locations matching your search criteria
United States
Kentucky
Lexington
University of Kentucky/Markey Cancer CenterStatus: Active
Contact: Adebola Adegboyega
Phone: 859-323-5196
PRIMARY OBJECTIVES:
I. Examine general awareness and cultural factors (fatalism, religiosity/spirituality, temporal orientation, medical mistrust, and acculturation) related to cancer control and prevention among African Americans and Sub Saharan African Immigrants.
II. Examine the socioecological barriers and facilitators to cervical cancer (CC) screening and self-sampling to inform tailoring of an evidenced based cervical health program to promote CC screening.
III. Assess feasibility, acceptability, and preliminary efficacy in a pilot test of the Health is Wealth: A Cervical Health Program among 30 African Americans (AA) and 30 Sub-Saharan African Immigrant (SAI) women using quasi-experimental design.
OUTLINE:
AIM 1: Participants complete a survey over 15-20 minutes.
AIM 2: Participants participate in a focus group session over 90-120 minutes or complete an audio-recorded interview over 30 minutes.
AIM 3: Participants complete Health is Wealth education session over 2 hours and receive human papillomavirus (HPV) self-sampling kits for HPV testing. Participants with a positive HPV result are offered assistance for scheduling an appointment for a Pap test and navigated to follow-up care within 1 month of receiving the result.
After completion of study, participants are followed up at 6 months.
Trial PhaseNo phase specified
Trial Typeprevention
Lead OrganizationUniversity of Kentucky/Markey Cancer Center
Principal InvestigatorAdebola Adegboyega